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Abstract. The purpose of this study was to observe, highlight and quantify the neuroprotective effects 
of these natural antioxidants’ administration. Chronic and acute exposure to hypobaric hypoxia (HH) 
induces changes of the pro-oxidant/antioxidant balance in the brain and throughout the body. It has 
been shown that natural antioxidants supplementation (Quercetin, Lycium barbarum and Chitosan) is 
effective in preventing the hypoxic stress. The present study was conducted on male, Wistar rats, 
exposed to acute and chronic hypobaric hypoxia (5500 m, 23h/day) for different periods of time (1 or 
14 days) or kept in normoxia for 14 days. Some of the rats were administered natural antioxidants one 
day before the first HH exposure and 14 days before and prior to every hypoxic exposure for the next 
14 days. At the end of the study the animals were euthanized and the brains were harvested and stored 
for further analysis. Brain sections were obtained and examined histopathologically to determine the 
number of neurons in necrosis/apoptosis. The results show a negative effect of chronic hypobaric 
hypoxia on the neurons viability and neuroprotective effects of natural antioxidants’ administration. 
This study suggests that the treatment with Quercetin, Lycium barbarum or Chitosan alone 
substantially ameliorated induced brain dysfunction and acts like a neuroprotectant. 
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INTRODUCTION 
 
High altitude exposure results in decreased partial pressure of oxygen and an increased 
formation of reactive oxygen and nitrogen species (RONS), which causes oxidative damage to 
lipids, proteins and DNA. Low barometric pressure at high altitude causes higher expression of 
hypoxia inducible factor (HIF). Diseases related to acute and chronic exposure to high-altitude 
are caused primarily by  hypobaric hypoxia (HH), which is considered as an physiological stress 
that affects the central nervous system and results in several physiological alterations (Romero 
et al, 2012). The severity and duration of the symptoms vary, depending on the altitude and rate 
of ascent, sometimes persisting after returning to lower altitudes (Imray et al., 2010). 
The development of these symptoms has been linked to hypoxia-induced oxidative and 
nitrosative stress (Bakonyi et al., 2004; Chiş et al, 2008). The RONS being alterations of: 
mitochondrial respiratory chain, cellular membrane and cytosol, endothelial cells and lipid 
and protein perturbations (Chandel et al, 1998). Generation of RONS may be one of the 
mechanisms caused the neuronal cell death after hypobaric hypoxia exposure (Hota SK et al., 
2008). Hypoxia plays a critical role in regulating many important signaling molecules and its 
functions in the central nervous system causing behavioral deficits due to reduced motor 
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activities, slow down of synaptic transmission and chronic hypoxia results in neuronal death 
(Sarkar et al., 2012). Bioactive compounds possessing neuroprotective properties have been 
proposed to be effective pharmacologically potent therapeutic agents in many diseases, 
including cognitive impairement (Farías et al., 2010; Vargas et al., 2011).  
Quercetin (2-(3,4-dihzdroxyphenyl)-3,5,7-tryhydroxy-4H-chromen-4-one) is an 
important flavonoid which is known to be a multi-functional agent, due to its anti-
inflammatory and anti-cancerous activities, as well as a potent antioxidant because of its 
directly scavenging ROS and free radicals (Annapurna et al, 2009; Galati et al., 2004; 
Hanasaki Y et al, 1994; Boots AW et al., 2008; Jeong SM et al., 2012).  
The recent studies showed in vitro the neuroprotective activities of Quercetin in different 
neuronal cell cultures (Sarkar et al., 2012).The fruits of Lycium barbarum (LBG), also known 
as Goji berry, belong to the Solanaceae family, have a wide antioxidant spectrum and have been 
used for a very long time in Easter-Asian medicine, especially in China (Yu et al., 2005). Also, 
LBG represent a rich source of vitamins, in particular riboflavin, thiamin and ascorbic acid; 
carotenoids; flavonoids; iron; selenium and germanium; and contains 18 types of amino acids, 
including taurine (a nonessential free amino acid). Recent research showed that LBG extract has 
many biologically beneficial effects, including anti-ageing, hypotensive effect, anti-apoptotic 
activity, antitumor and cytoprotective properties, immunostimulatory effects, etc.  
Eyesight improvement, blood pressure control, cholesterol level lowering, a good 
adjunct to combat the adverse effects of chemotherapy and radiotherapy in various tumors, 
etc. have also been reported (Deng et al., 2003; Gan L et al., 2004; Luo et al., 2004).  
Last but not least, this extract seems to have protective effects against the oxidative 
stress of different causes (Yu et al., 2005). Recent research has demonstrated neuroprotective 
effects or LBG extract (Chan et al., 2007; Yu et al., 2005). Chitosan is a α-(1-4)-D-
glucosamine polymer, a natural polysaccharide present in shellfish, clams, krill, oysters, 
fungi, etc (Cardenas et al., 2008). It has been shown to possess antilipidemic, anti-
ulcerogenic, anti-ageing, and membrane-stabilizing and antioxidant properties (Anandan et 
al., 2013; Filipovic-Grcic et al., 2001; Santhosh et al., 2006; Xie et al., 2001). 
The purpose of this study was to evaluate the efficiency of Quercetin, LBG extract or 
Chitosan supplementation in preventing neuronal tissue lesions induced by hypoxic stress the 
weather acute and chronic hypobaric hypoxia. 
 
MATERIALS AND METHODS 
 
Drugs and chemicals. The Chitosan used in this experiment were purchased from Sigma 
Chemical Company Inc., UK. The chemicals were of analytical grade. Quercetin and LBG were 
extracted, dosed and encapsulated at the “PROPLANTA” Applied Vegetal Biotechnologies 
Center in Cluj-Napoca. Quercetin, LBG extract and Chitosan were dissolved in saline solution. 
Animals. The study involved 90 albino Wistar male rats (weight 180-200 g, age 3 
months). All the animals were obtained from the Biobase of the “Iuliu Hatieganu” University of 
Medicine and Pharmacy, Cluj-Napoca. The animals were cared for in the Biobase of the 
Physiology Department of the same University. They were isolated for 10 days prior to their 
introduction in the study for acclimatization. The animals received a standard diet and their 
access to water was not restricted. All the experiments were conducted in agreement with the 
protocols and recommendations of the “Iuliu Hatieganu” University of Medicine and Pharmacy, 
Cluj-Napoca, Ethics Committee. The animals were randomly subdivided into nine experimental 
groups (n=10): 1st Group- unprotected acute hypoxic hypobaric (HH) rats (control group); 2nd 
Group- treated acute HH rats, rats treated with Quercetin; 3rd Group- treated acute HH rats, rats 
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treated with Lycium barbarum (LBG) extract; 4th Group- treated acute HH rats, rats treated 
with Chitosan; 5th Group- unprotected normoxia rats, rats not exposed to HH (control group); 
6th Group- treated chronic HH rats, rats treated with LBG extract; 7th Group- treated chronic 
HH rats, rats treated with Quercetin; 8th Group- treated chronic HH rats, rats treated with 
Chitosan and 9th Group- unprotected chronic HH rats (control group). 
The animals were exposed to a simulated altitude of 5500 m in a barochamber (in the 
Physiology Department of the UMF ˝Iuliu Haţieganu˝ Cluj-Napoca), where temperature and 
humidity were maintained at 28ºC and 55-60%, respectively, for one day (acute HH) and for 14 
consecutive days (chronic HH). The rats were taken out of the hypoxic chamber once after every 
24h exposure for 1 hour, for receiving food and water. Some of the rats received Quercetin (30 
mg/kg/day, dissolved in saline solution) or LBG extract (30 mg/kg/day, dissolved in saline 
solution) via an intragastric tube (0.6 ml/rat) for one day or 14 consecutive days prior to HH 
exposure and prior to every HH exposure respectively. Other groups were given intra-peritoneal 
injections of Chitosan (0,30-0,35 microg/animal/day, dissolved in saline solution) for a period of 
one day or 14 consecutive days prior to HH exposure and prior to every HH exposure 
respectively. The control groups were treated with saline solution (0.6 ml/rat) via an intragastric 
tube (ctrl groups). All rats were employed the next day after the last hypoxic exposure and 
sacrificed by decapitation (with sodium pentobarbital, 60 mg/rat ip). Brains were rapidly excised, 
washed in cold saline and used for analysis. For the histopathological examination the brain 
tissues were fixed in 10% neutral buffered formalin and, after proper fixation, were dehydrated in 
graded series of alcohol, cleared in Xilene and embedded in paraffin wax.  
Multiple longitudinal and transversal sections from each block were prepared at 5 µm, 
and stained with haematoxylin and eosin (H&E). The haematoxylin and eosin staining (H&E) 
was used, because it allows a good observation of different cell types. Tissue analysis was 
performed using an Olympus system for image acquisition and analysis, respectively an 
Olympus BX51 microscope equipped with Olympus Cell B software.  
Each sample of the brain tissue was examined to determine the number of neurons in 
necrosis/apoptosis. For this we used morphological criteria for assessing irreversible neuronal 
injury established by Farber et al. (1978), and Trump et al (1997). Optical microscopy can  
identify neurons in necrosis due to nuclear changes (pyknosis, cariorexa, carioliza) and cyto-
plasmic eosinophilia or loss of hematoxylin affinity, the so called "ghost neurons." Neurons 
suffering from other cellular changes, such as "dark neurons" and oedematous were also 
included in the count. Five microscope fields were examined from each area with 20x objective, 
setting the number of neurons in necrosis, then compared to the total number of neurons in each 
field, resulting the percentage of neurons in necrosis for the two areas taken in the study. 
Statistical analysis and all morphological data were performed using Shapiro-Wilk normality 
test, followed by the two-sample t-test, using R’software (R Development Core Team, 2010). 
 
 
RESULTS AND DISCUSSIONS 
 
Percentage of neuronal necrosis in control rats, HH-exposed rats ant treated HH-
exposed rats are illustrated in Figure 1. The number of neuronal necrosis in the hippocampus 
was statistically significantly increased in Groups 1 and 9 (acute and chronic hypobaric 
hypoxia exposed unprotected rats, p<0.001) as compared to the control group (5th Group). In 
the acute HH exposed rats, the damaging effect was less severe in 3th Group (p<0.01) as 
compared to the control group (5th Group), whereas in Groups 2 and 4, both treatments 
showed neuroprotective effects. In the case of chronic HH, in all three protected Groups (6th, 
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7th and 8th group) there were less damaged neurons as compared to the 9th Group 
(unprotected ctrl group) the best protective effect being observed in case of 6th Group.  
In the cerebral cortex, there was a similar trend regarding the number of viable 
neurons as the one seen in hippocampus. Thus, as expected, the most severe lesions were seen 
in both unprotected Groups (1 and 9). Following acute HH exposure, the best protective 
effects were seen in the treated animals from Groups 2 and 3, whereas in group 4 the 
neuroprotective effects were milder. All three treated Groups (6th, 7th and 8th group) in case 
of chronic HH exposure showed different degrees of protective effects estimated by the 
number of necrotic neurons as compared to the 9th Group (unprotected ctrl group) with a 
slightly better effect for animals from 7th Group and 8th Group. 
 
 
 
Fig. 1 Quantification of percentage of neuronal necrosis in the 9 experimental Wistar rats groups 
(Mean ± SD) *p<0.05; **p<0.01; ***p<0.001 as compared to the 5th Group (ctrl group). 
 
To further validate the effects of hypobaric hypoxia on brain tissue histopathological 
examination was conducted. Figures 2-3 present the histopathological analysis of the sections 
of brain tissues stained H&E from the rats exposed to normoxia, acute HH, chronic HH and 
treated acute or chronic HH. From each sample of the brain tissue were examined two areas, 
Ammon’s horn of hippocampus (Figure 2) and cerebral cortex respectively (Figure 3).  
Oral administration of Quercetin and LBG extract and intra-peritoneal injections of 
Chitosan revert neurodegeneration in the cerebral cortex and Ammon’s horn of hippocampus. 
Abnormal brain architecture and neuronal necrosis were observed in rat brains 
exposed to acute hypobaric hypoxia (1st Group) compared to the 5th Group (ctrl group).  
The rats treated with Quercetin, LBG extract and Chitosan respectively (2nd 
Group, 3th Group and 4th Group) and exposed to acute HH presented less severe of 
neuronal necrosis. The rats exposed to chronic hypobaric hypoxia (9th group) were 
presented characteristic changes due to chronic exposure to HH (neuronal necrosis visible 
due to nuclear changes: pyknosis, karyorrhexis, karyolysis) as well as cytoplasm eosino-
philia or loss of affinity for haematoxylin. The rats treated with Quercetin, LBG extract and 
Chitosan respectively (6th Group, 7th Group, 7th Group) and exposed to chronic HH 
presented the increased number of neuronal necrosis as compared with acute exposure to HH. 
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Fig. 2 Brain changes of rats exposed to normoxia, acute hypobaric hypoxia, chronic hypobaric  
hypoxia and treated acute or chronic hypobaric hypoxia. (A-J). Representative examples of 
histopathological analysis in the transverse sections from the Cross section through the Ammon’s horn of 
hippocampus stained with haematoxylin and eosin (H&E). The images were magnified 200 or 400 times.  
1st Group (A), 2nd Group (B), 3th Group (C) and 4th Group(D): no histological alterations were 
observed; 5th Group (E): no histological changes regarding neurons; 6th Group (F), 7th group (G) and 
8th group (H): restored towards normal; 9th Group (J): characteristic changes due to chronic exposure to 
HH (neuronal necrosis visible due to nuclear changes: pyknosis, karyorrhexis, karyolysis) as well as 
cytoplasmic eosinophilia or loss of affinity for hematoxylin compared to the 5th Group (ctrl group). 
   
1st group (A) (H&Ex200). 
 
2nd group (B) (H&Ex200). 3th group (C) (H&Ex200). 
   
4th (D) (H&Ex200). 
 
5th groups (E) (H&Ex400). 6th group (F) (H&Ex400). 
   
7th group (G) (H&Ex400). 8th group (H) (H&Ex400). 9th group (J) (H&Ex200). 
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Fig. 3 Brain changes of rats exposed to normoxia, acute hypobaric hypoxia, chronic hypobaric  
hypoxia and treated acute or chronic hypobaric hypoxia. (A-J). Representative examples of 
histopathological analysis in the transverse sections from the Cross section through the cerebral cortex 
stained with haematoxylin and eosin (H&E). The images were magnified 200 or 400 times.  
1st Group (A),  2nd Group (B), 3th Group (C) and 4th Group(D): no histological alterations were 
observed; 5th Group (E): no histological changes regarding neurons; 6th Group (F), 7th group (G) and 
8th group (H): restored towards norma; 9th Group (J): characteristic changes due to chronic exposure 
to HH (neuronal necrosis visible due to nuclear changes: pyknosis, karyorrhexis, karyolysis) as well as 
cytoplasm eosinophilia or loss of affinity for haematoxylin compared to the 5th Group (ctrl group). 
 
Recent studies (Hota et al., 2008) have shown that exposure to chronic hypobaric 
hypoxia has a negative effect on the viability of neurons, particularly in the hippocampus, 
   
1st group (A) neuronal necrosis 
(arrows) (H&Ex200). 
2nd group (B), (H&Ex200). 3th group (C) (H&Ex200). 
   
4th group (D) (H&Ex200). 5th group (E) (H&Ex400). 6th group (F), (H&Ex400). 
   
7th group (G) (H&Ex400). 8th group (H) (H&Ex400). 9th group (J) (H&Ex400). 
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aspects seen by the increased number of cells showing DNA defragmentation, a cellular 
apoptosis index, in animals that were subjected for 14 days to hypobaric hypoxia. The same 
aspect was observed in the present study, the number of cell necrosis/apoptosis was increased in 
the groups with chronic hypobaric hypoxia (14 days) compared with groups subjected to one 
day of hypobaric hypoxia. The extract from Lycium barbarum (LBG) can protect neurons from 
cell death, this cytoprotective effect has been studied and demonstrated repeatedly (Yu MS et 
al., 2005; Chan et al., 2007). Our results suggest that the extract from LBG has novel protective 
effects in neurons against reducing the percentage of neurons in necrosis/apoptosis in rats 
exposed to hypobaric hypoxia and treated with LBG extract, compared to the control rats.  
The extract from LBG has been investigated extensively in the last years. The biological 
effects of LBG include anti-aging, anti-oxidation, anti-tumor and immuno-stimulating (Deng et 
al., 2003; Gan L et al., 2004; Luo et al., 2004). The anti-oxidative property of LBG should be 
attributed to its rich anti-oxidants such as carotenoids, riboflavin, ascorbic acid, thiamine and 
nicotinic acid (Luo et al., 2004). The cytoprotective effects of LBG against oxidative stress 
neuronal death has been amply studied in the last years (Chan et al., 2007; Yu et al., 2005, 2006). 
Sarkar A. et al (2012) demonstrated the neuroprotective effects of Quercetin in the 
exposure of hypobaric hypoxia, aspect seen with this study that rats exposed to hypobaric 
hypoxia and treated with Quercetin showed less cell necrosis/apoptosis compared to the 
control rats and also compared to rats exposed to hypobaric hypoxia and treated with LBG. 
The Chitosan also has a protective effect on neurons. Koo et al. (2002) in a study of in 
vitro cell culture, demonstrated anti-apoptotic effect of Chitosan on astrocytes, and Zhu et al. 
(2010) demonstrated the same effect on neuronal cell cultures. This neuroprotective effect 
was observed in the present study, the percentage of neuronal necrosis being lower than 
control group. Exposure to high-altitude results in hypobaric hypoxia which is considered as 
an acute physiological stress. This condition often leads to injuries such as cerebral edema 
high altitude pulmonary edema and hypoxic muscle weakness (Sarkar et al., 2012). Quercetin 
is the most active of the flavonoids, antioxidants used in the altitude sickness. 
Patir et al. (2012) showed that in rats, Quercetin reduces inflammation and cerebral 
edema associated with altitude disease without the side effects of steroid therapy. In a recent 
study in rats of Zhou et al. (2012) demonstrated that Quercetin increases the activity of 
superoxide dismutase, catalase, glutathione peroxidase and glutathione levels, decreased 
serum levels of malonildialdehyde. These results suggest that Quercetin effects on neuronal 
function and metabolism could be due to potential protective antioxidants against hypobaric 
hypoxia-induced lesions. Neuroprotective effects of Quercetin on ischemia reperfusion injury 
in rats are due to attenuation of oxidative stress and increase antioxidant reserves. 
According to recent studies (Rybnikov et al., 2012) it has been shown that hypoxic 
hypobaric protects neurons from post-hypoxic injury, greatly reducing the number of neuronal 
necrosis (aspects measured by the reduced number of neurons in pyknosis, respectively 
hypercromatosis) and interstitial cerebral edema. Similar to that study, Zhu et al. (2012) 
showed that intermittent hypobaric hypoxia stimulates the proliferation of endogenous neuron 
progenitors, forming new neurons in the adult rat hippocampus and also anti-depressive 
effects demonstrated by certain tests (forced swim test, etc.). We observed that the rats 
exposed to acute and chronic hypobaric hypoxia presented progressive necrosis lesions, in 
different evolving stages. Brain lesions were aggravated by the chronic hypobaric hypoxia 
exposure. The rats treated with Quercetin, LBG extract and Chitosan respectively, and exposed 
to hypobaric hypoxia presented a decrease of the brain lesions. 
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CONCLUSION 
 
These results demonstrate the beneficial effects of Quercetin, Lycium barbarum and 
Chitosan supplementation in natural and enriched foods. These substances presented a 
neuroprotective effect induced by hypobaric hypoxia. Our results demonstrate a neuroprotective 
role of Quercetin, Chitosan and Lycium barbarum in mediating the increased tolerance to 
ischemia observed in the chronically hypoxic brain. 
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